Edition:
United Kingdom

Smith & Nephew PLC (SN.L)

SN.L on London Stock Exchange

1,352.00GBp
4:35pm BST
Change (% chg)

11.00 (+0.82%)
Prev Close
1,341.00
Open
1,347.50
Day's High
1,352.50
Day's Low
1,334.50
Volume
2,231,658
Avg. Vol
2,994,833
52-wk High
1,442.00
52-wk Low
1,173.00

Select another date:

Wed, Apr 4 2018

Photo

Smith & Nephew picks new CEO who sold his last company

LONDON Artificial hip and knee maker Smith & Nephew , a perennial target of takeover speculation, said on Wednesday it had appointed a new chief executive with a track record of deal-making.

RPT-UPDATE 1-Smith & Nephew picks new CEO who sold his last company

LONDON, April 4 Artificial hip and knee maker Smith & Nephew, a perennial target of takeover speculation, said on Wednesday it had appointed a new chief executive with a track record of deal-making.

Smith & Nephew names Namal Nawana new CEO

LONDON, April 4 Artificial hip and knee maker Smith & Nephew said on Wednesday it had appointed Namal Nawana to replace Olivier Bohuon as chief executive of the British company next month.

BRIEF-Smith & Nephew Announces Full Commercial Release Of Journey II XR Total Knee Arthroplasty​

* SMITH & NEPHEW PLC - ANNOUNCES FULL COMMERCIAL RELEASE OF JOURNEY II XR TOTAL KNEE ARTHROPLASTY​ Source text for Eikon: Further company coverage:

Smith & Nephew meets lower end of guidance range for 2017

LONDON, Feb 8 Artificial hip and knee maker Smith & Nephew scraped into the bottom of its guidance range for 2017, with a 3 percent rise in revenue to $4.77 billion pounds and a 20 basis point increase in its trading margin, resulting in profit of $1.05 billion.

BRIEF-Smith & Nephew Sees Corporate Tax Rate On Trading Results In 20-21 Pct Range From 2018

* ‍AS RESULT OF US TAX CHANGE, FROM 2018 NOW EXPECTS A CORPORATE TAX RATE ON TRADING RESULTS IN RANGE 20% TO 21% FOR MEDIUM TERM​

BRIEF-Smith & Nephew announces acquisition of Rotation Medical Inc​

* ‍ACQUISITION COST IS $125 MILLION AND UP TO A FURTHER $85 MILLION OVER NEXT FIVE YEARS, CONTINGENT ON FINANCIAL PERFORMANCE​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Under pressure Smith & Nephew to focus on efficiency

LONDON Smith & Nephew said no major surgery is required for the artificial knee and hip maker to deliver shareholder value, even as it reported lacklustre sales that increase pressure on the company reportedly being stalked by activist investor Elliott.

UPDATE 2-Under pressure Smith & Nephew to focus on efficiency

* Says full-year growth will be at lower end of 3-4 pct guidance

BRIEF-S&N CEO will not confim if activist investor Elliott has stake

* Ceo says cost savings plan will be finalised by year-end results in feb

Select another date: